J. Hepatol.
Advances in resection and transplantation for hepatocellular carcinoma.
Vibert E, Schwartz M, Olthoff KM
It would be impossible to summarise all of the significant developments in the surgical management of hepatocellular carcinoma (HCC), even just over t ...
Read More
Source: PubMed
Eur J Med Chem
Molecular design, synthesis, and biological evaluation of bisamide derivatives as cyclophilin A inhibitors for HCV treatment.
Han J, Lee HW, Jin Y, Khadka DB, Yang S, Li X, Kim M, Cho WJ
Hepatitis C virus (HCV) is a major cause of end-stage liver diseases. Direct-acting antivirals (DAAs), including inhibitors of nonstructural proteins ...
Read More
Source: PubMed
J Clin Transl Hepatol
Highlights for Dental Care as a Hepatitis C Risk Factor: A Review of Literature.
Averbukh LD, Wu GY
Hepatitis C (HCV) is a viral infection that affects an estimated 71 million people worldwide, with over 1 million new infections yearly. While medical ...
Read More
Source: PubMed
Gastroenterol Nurs
Management of Hepatitis C: A Practical Primer for Nurses.
Guss D, Sherigar J, Mohanty SR
Nurses have been at the forefront of the care of patients with hepatitis C since hepatitis C virus was identified in 1989. Treatments of patients with ...
Read More
Source: PubMed
World J. Gastroenterol.
Expanding the donor pool: Hepatitis C, hepatitis B and human immunodeficiency virus-positive donors in liver transplantation.
Crismale JF, Ahmad J
Liver transplantation (LT) remains the best option for patients with end-stage liver disease but the demand for organs from deceased donors continues ...
Read More
Source: PubMed
